Weekly shot shows promise for blood sugar and weight control in type 1 diabetes

NCT ID NCT05537233

Completed Disease control Sponsor: Viral N. Shah Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 28 times

Summary

This study tested a once-weekly injection of semaglutide in 115 adults with type 1 diabetes and obesity who were already using an automated insulin pump system. The goal was to see if the drug could help them achieve better blood sugar control (more time in target range) and lose at least 5% of their body weight. Participants were followed for 26 weeks, and results were compared to a placebo group.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Barbara Davis Center for Diabetes

Aurora, Colorado, 80045, United States
Harold Schnitzer Diabetes Health Center

Portland, Oregon, 97239, United States
Henry Ford Hospital

Detroit, Michigan, 48202, United States
Iowa Diabetes Research Center

West Des Moines, Iowa, 50265, United States

Conditions

Explore the condition pages connected to this study.

OBESITY TYPE 1 DIABETES